farnesol has been researched along with betadex in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barreto, AS; Batista, MVA; Carvalho, JS; de Souza Araújo, AA; Dos Santos, DM; Oliveira Santos, LAB; Oliveira, AMS; Quintans-Júnior, LJ; Serafini, MR; Silva, EAP; Siqueira Quintans, JS; Viana Santos, MR | 1 |
| Blanco-López, M; Curto, B; de Dios-Pérez, I; García-Esteban, JA; González-Garcinuño, Á; Martín Del Valle, EM; Moreno-Rodilla, V; Pérez-Esteban, P; Tabernero, A | 1 |
2 other study(ies) available for farnesol and betadex
| Article | Year |
|---|---|
Cardiovascular effects of farnesol and its β-cyclodextrin complex in normotensive and hypertensive rats.
Topics: Animals; Arterial Pressure; beta-Cyclodextrins; Blood Pressure; Bradycardia; Cardiovascular Agents; Dose-Response Relationship, Drug; Enzyme Inhibitors; Farnesol; Heart Rate; Hypertension; Male; Molecular Docking Simulation; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Wistar | 2021 |
Development of a thermosensitive hydrogel based on Polaxamer 407 and gellan gum with inclusion complexes (Sulfobutylated-β-cyclodextrin-Farnesol) as a local drug delivery system.
Topics: beta-Cyclodextrins; Drug Delivery Systems; Farnesol; Hydrogels; Poloxamer; Polysaccharides, Bacterial | 2023 |